Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

34.90
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
26.95
Today|||52-Week Range
51.10
-23.55%
Year-to-Date

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 41.50, with a high estimate of 80.00 and a low estimate of 27.00. The median estimate represents a +18.91% increase from the last price of 34.90.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.05
Sales
$76.9M
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 130.56%
 
 
 
 
 
 
Growthannually 12.96%
 
 
 
 
 
 

Sales

Growthquarterly 3.06%
 
 
 
 
 
 
Growthannually 9.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.